Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:43:52.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:52:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, effectively blocking access to the study record. Most study-related navigation and document links appear to have been removed.
    Difference
    21%
    Check dated 2026-09-23T01:08:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The site's revision tag was updated from v3.6.6 to v3.7.0, indicating a new software release; no study content or user-facing features appear to be affected.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.6, replacing the previous v3.6.5. This is a minor, behind-the-scenes update that does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T21:46:22.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study overview alongside other identifiers, representing an additional funding reference for the INSIGHT trial.
    Difference
    0.0%
    Check dated 2026-08-25T22:15:33.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.